Dr Morgan Cecil Eddmenson, PHARMD | |
720 W Byers Ave, Owensboro, KY 42303-6330 | |
(270) 683-2400 | |
(270) 685-4825 |
Full Name | Dr Morgan Cecil Eddmenson |
---|---|
Gender | Female |
Speciality | Pharmacist - Pharmacist Clinician (phc)/ Clinical Pharmacy Specialist |
Location | 720 W Byers Ave, Owensboro, Kentucky |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1063124857 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
1835P0018X | Pharmacist - Pharmacist Clinician (phc)/ Clinical Pharmacy Specialist | 023191 (Kentucky) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Morgan Cecil Eddmenson, PHARMD 720 W Byers Ave, Owensboro, KY 42303-6330 Ph: (270) 683-2400 | Dr Morgan Cecil Eddmenson, PHARMD 720 W Byers Ave, Owensboro, KY 42303-6330 Ph: (270) 683-2400 |
News Archive
Diabetes causes more new cases of legal blindness among working-age Americans than any other disease. If diabetics are monitored regularly by their ophthalmologist, this vision loss is almost always avoidable. Yet, tragically, more than half of all people living with diabetes do not get the recommended annual dilated eye exam.
More than 175 organizations issued a letter of support today to the President, the U.S. Senate and U.S. House of Representatives to strongly support comprehensive health reform efforts, emphasizing the need to modernize and increase funding for disease prevention, wellness, and public health in the United States.
In two states in India, Tamil Nadu and Andhra Pradesh, COVID-19 cases and deaths have been more heavily concentrated in younger cohorts than is seen in high-income countries, among other trends.
Captozyme, Inc. announced today that it is initiating a prospective double-blind, randomized, placebo controlled, cross-over study, with Nephure, an oxalate reducing enzyme, to determine the extent to which Nephure vs. placebo reduces urinary oxalate excretion (mg/24 hour) in healthy subjects who are provided a controlled diet.
Covidien, a leading global provider of healthcare products, today announced that the U.S. Food and Drug Administration (FDA) recently granted approval to the company's Mallinckrodt business for morphine sulfate oral solution, used to relieve moderate to severe acute and chronic pain in opioid-tolerant patients. The solution will be available as a generic in 100 milligrams per 5 mL (20 milligrams per 1 mL).
› Verified 3 days ago
Dr. Stephanie Lynn Wright, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1921 W Parrish Ave, Owensboro, KY 42301 Phone: 270-683-0223 | |
Dr. Johnathan T Fuller, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2318 Frederica St, Owensboro, KY 42301 Phone: 270-686-7873 Fax: 270-686-7864 | |
Lesley Erin Rose, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1670 Starlite Dr, Owensboro, KY 42301 Phone: 270-926-2340 Fax: 270-926-3864 | |
Mrs. Kristen C Hayden, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1000 E 4th St, Owensboro, KY 42303 Phone: 270-683-1571 Fax: 270-926-4619 | |
Jordan Daniel Hayes, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1735 Scherm Rd, Owensboro, KY 42301 Phone: 270-685-3143 Fax: 270-684-4235 | |
Sara Elizabeth Campbell, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 5031 Frederica St, Owensboro, KY 42301 Phone: 270-685-0027 | |
Mr. Joseph Alan Hill, R.PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3300 Calumet Trace, Owensboro, KY 42303 Phone: 270-683-6327 |